Corentec Co Ltd (104540) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Corentec Co Ltd (104540) has a cash flow conversion efficiency ratio of 0.100x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩8.50 Billion ≈ $5.76 Million USD) by net assets (₩85.14 Billion ≈ $57.70 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 104540 market cap overview for the company's overall valuation and market capitalisation.
Corentec Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Corentec Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Corentec Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Corentec Co Ltd ranked by their cash flow conversion efficiency. Explore 104540 cash to earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
US Energy Corp
NASDAQ:USEG
|
-0.006x |
|
Mtag Group Berhad
KLSE:0213
|
-0.016x |
|
DONGJIANG ENVIRONMENTAL H
F:DGN
|
N/A |
|
Biohit Oyj B
HE:BIOBV
|
0.040x |
|
Verusaturk Girisim Sermayesi
IS:VERTU
|
0.003x |
|
Culp, Inc. Common Stock
NYSE:CULP
|
-0.022x |
|
Filana Therapeutics, Inc.
NASDAQ:FLNA
|
-0.061x |
|
Star Equity Holdings Inc
NASDAQ:STRR
|
-0.059x |
Annual Cash Flow Conversion Efficiency for Corentec Co Ltd (2013–2024)
The table below shows the annual cash flow conversion efficiency of Corentec Co Ltd from 2013 to 2024. View Corentec Co Ltd (104540) share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩71.98 Billion ≈ $48.78 Million |
₩-6.61 Billion ≈ $-4.48 Million |
-0.092x | -400.04% |
| 2023-12-31 | ₩86.12 Billion ≈ $58.36 Million |
₩2.63 Billion ≈ $1.79 Million |
0.031x | -81.03% |
| 2022-12-31 | ₩65.75 Billion ≈ $44.56 Million |
₩10.60 Billion ≈ $7.18 Million |
0.161x | +124.02% |
| 2021-12-31 | ₩56.63 Billion ≈ $38.38 Million |
₩4.08 Billion ≈ $2.76 Million |
0.072x | +192.57% |
| 2020-12-31 | ₩46.41 Billion ≈ $31.45 Million |
₩-3.61 Billion ≈ $-2.44 Million |
-0.078x | -160.37% |
| 2019-12-31 | ₩29.94 Billion ≈ $20.29 Million |
₩3.86 Billion ≈ $2.61 Million |
0.129x | -41.02% |
| 2018-12-31 | ₩24.09 Billion ≈ $16.32 Million |
₩5.26 Billion ≈ $3.56 Million |
0.218x | +102.32% |
| 2017-12-31 | ₩54.32 Billion ≈ $36.81 Million |
₩5.86 Billion ≈ $3.97 Million |
0.108x | +120.77% |
| 2016-12-31 | ₩60.18 Billion ≈ $40.79 Million |
₩2.94 Billion ≈ $1.99 Million |
0.049x | +8.09% |
| 2015-12-31 | ₩56.27 Billion ≈ $38.13 Million |
₩2.54 Billion ≈ $1.72 Million |
0.045x | +384.68% |
| 2014-12-31 | ₩48.30 Billion ≈ $32.73 Million |
₩450.70 Million ≈ $305.43K |
0.009x | -60.24% |
| 2013-12-31 | ₩44.48 Billion ≈ $30.15 Million |
₩1.04 Billion ≈ $707.46K |
0.023x | -- |
About Corentec Co Ltd
Corentec Co., Ltd., develops and sells orthopedic artificial joints in South Korea. Its orthopedic products include hip systems, such as Bencox ID stems, Bencox stems, Bencox modular revision stems, Bencox m stems, and Benfix long stems; and Bencox cups, Bencox bipolar cups, Bencox mirabo cups, and Bencox mirabo multi-hole cups. The company also offers Lospa and Exult knee systems; spine systems,… Read more